These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Identification of a new complementation group of the peroxisome biogenesis disorders and PEX14 as the mutated gene. Shimozawa N; Tsukamoto T; Nagase T; Takemoto Y; Koyama N; Suzuki Y; Komori M; Osumi T; Jeannette G; Wanders RJ; Kondo N Hum Mutat; 2004 Jun; 23(6):552-8. PubMed ID: 15146459 [TBL] [Abstract][Full Text] [Related]
8. Identification of the molecular defect in patients with peroxisomal mosaicism using a novel method involving culturing of cells at 40 degrees C: implications for other inborn errors of metabolism. Gootjes J; Schmohl F; Mooijer PA; Dekker C; Mandel H; Topcu M; Huemer M; Von Schütz M; Marquardt T; Smeitink JA; Waterham HR; Wanders RJ Hum Mutat; 2004 Aug; 24(2):130-9. PubMed ID: 15241794 [TBL] [Abstract][Full Text] [Related]
9. Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders. Chang CC; Lee WH; Moser H; Valle D; Gould SJ Nat Genet; 1997 Apr; 15(4):385-8. PubMed ID: 9090384 [TBL] [Abstract][Full Text] [Related]
10. Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders. Portsteffen H; Beyer A; Becker E; Epplen C; Pawlak A; Kunau WH; Dodt G Nat Genet; 1997 Dec; 17(4):449-52. PubMed ID: 9398848 [TBL] [Abstract][Full Text] [Related]
11. Isolation of a new peroxisome-deficient CHO cell mutant defective in peroxisome targeting signal-1 receptor. Tsukamoto T; Bogaki A; Okumoto K; Tateishi K; Fujiki Y; Shimozawa N; Suzuki Y; Kondo N; Osumi T Biochem Biophys Res Commun; 1997 Jan; 230(2):402-6. PubMed ID: 9016792 [TBL] [Abstract][Full Text] [Related]
12. Genomic structure of PEX13, a candidate peroxisome biogenesis disorder gene. Björkman J; Stetten G; Moore CS; Gould SJ; Crane DI Genomics; 1998 Dec; 54(3):521-8. PubMed ID: 9878256 [TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of novel phenotype CHO cell mutants defective in peroxisome assembly, using ICR191 as a potent mutagenic agent. Ghaedi K; Fujiki Y Cell Biochem Funct; 2008 Aug; 26(6):684-91. PubMed ID: 18543353 [TBL] [Abstract][Full Text] [Related]
15. The peroxin Pex6p gene is impaired in peroxisomal biogenesis disorders of complementation group 6. Matsumoto N; Tamura S; Moser A; Moser HW; Braverman N; Suzuki Y; Shimozawa N; Kondo N; Fujiki Y J Hum Genet; 2001; 46(5):273-7. PubMed ID: 11355018 [TBL] [Abstract][Full Text] [Related]
16. Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome. Shimozawa N; Tsukamoto T; Suzuki Y; Orii T; Fujiki Y J Clin Invest; 1992 Nov; 90(5):1864-70. PubMed ID: 1430210 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological induction of peroxisomes in peroxisome biogenesis disorders. Wei H; Kemp S; McGuinness MC; Moser AB; Smith KD Ann Neurol; 2000 Mar; 47(3):286-96. PubMed ID: 10716247 [TBL] [Abstract][Full Text] [Related]
18. Temperature-sensitive mutation of PEX6 in peroxisome biogenesis disorders in complementation group C (CG-C): comparative study of PEX6 and PEX1. Imamura A; Shimozawa N; Suzuki Y; Zhang Z; Tsukamoto T; Fujiki Y; Orii T; Osumi T; Wanders RJ; Kondo N Pediatr Res; 2000 Oct; 48(4):541-5. PubMed ID: 11004248 [TBL] [Abstract][Full Text] [Related]
19. A novel defect of peroxisome division due to a homozygous non-sense mutation in the PEX11β gene. Ebberink MS; Koster J; Visser G; Spronsen Fv; Stolte-Dijkstra I; Smit GP; Fock JM; Kemp S; Wanders RJ; Waterham HR J Med Genet; 2012 May; 49(5):307-13. PubMed ID: 22581968 [TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of detectable catalase-containing particles, peroxisomes, in fibroblasts from a PEX2-defective patient. Shimozawa N; Zhang Z; Imamura A; Suzuki Y; Fujiki Y; Tsukamoto T; Osumi T; Aubourg P; Wanders RJ; Kondo N Biochem Biophys Res Commun; 2000 Feb; 268(1):31-5. PubMed ID: 10652207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]